Literature DB >> 17669406

The combined effect of age and basal follicle-stimulating hormone on the cost of a live birth at assisted reproductive technology.

Melinda B Henne1, Barbara J Stegmann, Adrienne B Neithardt, William H Catherino, Alicia Y Armstrong, Tzu-Cheg Kao, James H Segars.   

Abstract

OBJECTIVE: To predict the cost of a delivery following assisted reproductive technologies (ART).
DESIGN: Cost analysis based on retrospective chart analysis.
SETTING: University-based ART program. PATIENT(S): Women aged >or=26 and <or=42 years with FSH levels <or=12 IU/L on day 3 undergoing a first cycle of fresh, nondonor ART. INTERVENTION(S): Logit regression using a fractional polynomial model of age and basal FSH was used to estimate the probability of a live birth. Cost analysis was applied to the resulting prediction. MAIN OUTCOME MEASURE(S): The predicted probability of a live birth following ART based on a woman's age and FSH and the associated cost of a live birth. RESULT(S): Analysis of 1,238 first ART cycles produced a prediction model for live birth rates following ART incorporating both age and FSH. A cost analysis based upon combination of age and FSH revealed the cost of a live birth exceeded $100,000 when the probability of a live birth fell below 15% and the cost rose exponentially at lower probabilities of live birth. CONCLUSIONS(S): Based upon a woman's age and FSH and expected cost for a live birth using ART may be calculated. At live birth rates <5%, the cost of ART is high and greatly exceeds the cost of donor cycles. This information is vital for patient counseling.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17669406      PMCID: PMC2278028          DOI: 10.1016/j.fertnstert.2007.02.016

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  24 in total

Review 1.  Cost-effectiveness of in vitro fertilization.

Authors:  J Collins
Journal:  Semin Reprod Med       Date:  2001-09       Impact factor: 1.303

Review 2.  Economic implications of assisted reproductive techniques: a systematic review.

Authors:  L Garceau; J Henderson; L J Davis; S Petrou; L R Henderson; E McVeigh; D H Barlow; L L Davidson
Journal:  Hum Reprod       Date:  2002-12       Impact factor: 6.918

3.  Blastocyst transfer decreases multiple pregnancy rates in in vitro fertilization cycles: a randomized controlled trial.

Authors:  John L Frattarelli; Mark P Leondires; Jeffrey L McKeeby; Bradley T Miller; James H Segars
Journal:  Fertil Steril       Date:  2003-01       Impact factor: 7.329

4.  To pay or not to pay.

Authors:  Tarun Jain; Mark D Hornstein
Journal:  Fertil Steril       Date:  2003-07       Impact factor: 7.329

5.  Biological versus chronological ageing of oocytes, distinguishable by raised FSH levels in relation to the success of IVF treatment.

Authors:  V A Akande; C F Fleming; L P Hunt; S D Keay; J M Jenkins
Journal:  Hum Reprod       Date:  2002-08       Impact factor: 6.918

6.  Microdose follicular phase gonadotropin-releasing hormone agonist (GnRH-a) compared with luteal phase GnRH-a for ovarian stimulation at in vitro fertilization.

Authors:  M P Leondires; M Escalpes; J H Segars; R T Scott; B T Miller
Journal:  Fertil Steril       Date:  1999-12       Impact factor: 7.329

Review 7.  Cost-effective treatment for the couple with infertility.

Authors:  B J Van Voorhis; C H Syrop
Journal:  Clin Obstet Gynecol       Date:  2000-12       Impact factor: 2.190

8.  Reproductive outcome in patients with diminished ovarian reserve.

Authors:  A J Levi; M F Raynault; P A Bergh; M R Drews; B T Miller; R T Scott
Journal:  Fertil Steril       Date:  2001-10       Impact factor: 7.329

Review 9.  An international survey of the health economics of IVF and ICSI.

Authors:  JohnA Collins
Journal:  Hum Reprod Update       Date:  2002 May-Jun       Impact factor: 15.610

10.  Prognostic assessment of female fecundity.

Authors:  D Navot; Z Rosenwaks; E J Margalioth
Journal:  Lancet       Date:  1987-09-19       Impact factor: 79.321

View more
  6 in total

1.  Expensive but worth it: older parents' attitudes and opinions about the costs and insurance coverage for in vitro fertilization.

Authors:  Robert D Nachtigall; Kirstin MacDougall; Anne C Davis; Yewoubdar Beyene
Journal:  Fertil Steril       Date:  2011-11-25       Impact factor: 7.329

Review 2.  A new approach to ovarian reserve testing.

Authors:  Wenjie Sun; Barbara J Stegmann; Melinda Henne; William H Catherino; James H Segars
Journal:  Fertil Steril       Date:  2008-04-22       Impact factor: 7.329

3.  When is clomiphene or gonadotropin intrauterine insemination futile? Results of the Fast Track and Standard Treatment Trial and the Forty and Over Treatment Trial, two prospective randomized controlled trials.

Authors:  Daniel J Kaser; Marlene B Goldman; June L Fung; Michael M Alper; Richard H Reindollar
Journal:  Fertil Steril       Date:  2014-09-16       Impact factor: 7.329

4.  Outcome of assisted reproductive technology in women aged 40 years and older.

Authors:  Abbas Aflatoonian; Maryam Eftekhar; Farnaz Mohammadian; Fariba Yousefnejad
Journal:  Iran J Reprod Med       Date:  2011

5.  Testing for Ovarian Reserve in Assisted Reproduction programs: the current point of view.

Authors:  F J Broekmans
Journal:  Facts Views Vis Obgyn       Date:  2009

6.  Individual patient data meta-analysis of diagnostic and prognostic studies in obstetrics, gynaecology and reproductive medicine.

Authors:  Kimiko A Broeze; Brent C Opmeer; Lucas M Bachmann; Frank J Broekmans; Patrick M M Bossuyt; Sjors F P J Coppus; Neil P Johnson; Khalid S Khan; Gerben ter Riet; Fulco van der Veen; Madelon van Wely; Ben W J Mol
Journal:  BMC Med Res Methodol       Date:  2009-03-27       Impact factor: 4.615

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.